The Necessity of Brain Tissue Examination in Diagnosing Death with CTE: Clarifying Contractual Interpretation in NFL Concussion Litigation

The Necessity of Brain Tissue Examination in Diagnosing Death with CTE: Clarifying Contractual Interpretation in NFL Concussion Litigation

Introduction

In this case, a group of eighteen retired NFL players—represented by their claimants—brought forward claims seeking compensation under the NFL Concussion Settlement Agreement. The claims were based on diagnoses of "Death with Chronic Traumatic Encephalopathy (CTE)" submitted via letters from a board-certified neuropathologist. The dispute arose when the Claims Administrator, supported by the Special Master and later by the District Court, denied the claims on the grounds that the diagnoses did not include the mandatory post-mortem brain tissue examination. This commentary examines the court's reasoning, the legal precedents relied upon, and the implications of this judgment for future litigation under similar settlement agreements.

The case involves key issues central to both contractual interpretation and the scientific standards required for diagnosing CTE. The primary parties include the retired NFL players (represented by their claimants) and the NFL's legal representatives, with counsel representing both sides and arguments heard by the United States Court of Appeals, Third Circuit.

Summary of the Judgment

The District Court, with its decision subsequently affirmed by the Third Circuit Court of Appeals, held that the claims for compensation based on diagnoses of Death with CTE were properly denied. The Court’s decision was grounded in the language and interpretation of the Settlement Agreement, which – according to the District Court’s reading, supported by prior judicial opinions – requires a post-mortem diagnosis to be based on a brain tissue examination. The appellant claimants had submitted affidavits from a board-certified neuropathologist that failed to include evidence of such an examination. The Court, citing clear precedents and scientific standards, concluded that without the brain tissue review, the diagnosis did not satisfy the requirements laid out in the Settlement Agreement.

Analysis

Precedents Cited

The judgment relied heavily on both older and recent precedents pertinent to the interpretation of the Settlement Agreement:

  • In re Nat'l Football League Players Concussion Inj. Litig. (2016): This precedent underscored that diagnosing CTE requires the identification of abnormal tau protein accumulations in brain tissue. The language emphasized that Death with CTE inherently involves a "post-mortem diagnosis," which must be based on scientific evidence obtained from examining brain tissue.
  • District Court’s 2015 Approval Opinion: This earlier opinion reinforced that the diagnosis of CTE is dependent on the microscopic examination of brain sections to confirm the presence and pattern of abnormally phosphorylated tau proteins.

Both sets of precedents played a critical role in establishing that the Settlement Agreement’s requirements mandate a post-mortem brain tissue review, without which a diagnosis of Death with CTE would remain unsubstantiated.

Legal Reasoning

The Court’s legal reasoning was multifaceted and can be broken down as follows:

  1. Contractual Interpretation: The Settlement Agreement was first treated as an unambiguous contract, where its terms—particularly “neuropathologist” and “post-mortem”—dictated that the diagnosis must be made via the examination of brain tissue. The plain language of the contract, read in context, did not allow for alternative diagnostic methods.
  2. Ambiguity and Extrinsic Evidence: Even if ambiguity was alleged, the District Court was justified in considering extrinsic evidence, notably prior judicial opinions and scientific literature that confirm that CTE requires microscopic examination. The Court viewed this extrinsic evidence as reinforcing a reasonable interpretation of the contract.
  3. Review of Evidentiary Standards: The Court applied a “clear error” standard when reviewing the District Court’s factual determinations, emphasizing that without the requisite brain tissue examination, the claims did not meet the standards set out in prior approvals and in the scientific understanding of CTE.

Impact on Future Cases and Legal Doctrine

This judgment may have a significant impact on future litigation related to sports-related concussion settlements. The decision clarifies that:

  • Settlement agreements, especially those in mass litigations, must be interpreted in light of both the plain language and the relevant scientific and technical evidence.
  • Diagnostic criteria incorporated into settlement agreements carry binding requirements, particularly when linked to scientific standards, such as post-mortem examinations in the case of CTE.
  • Parties challenging contractual determinations based on due process claims must contend with the established court interpretations that prioritize clear, evidentiary standards.

In effect, the judgment reinforces the necessity for objective and scientifically verifiable evidence when claims involve technical medical diagnoses. This stands as a reminder to both legal drafters and litigants that the specificity in contractual language can have far-reaching consequences when the context calls upon specialized knowledge.

Complex Concepts Simplified

Several legal concepts underpin this judgment. Below are simplified explanations:

  • Settlement Agreement Interpretation: This refers to how courts analyze and derive meaning from the written terms of a contract. In this case, the clear language regarding “post-mortem” and “neuropathologist” required that a diagnosis be based on an examination of brain tissue.
  • Clear Error Standard: When an appellate court reviews a lower court’s decision, it will only overturn findings if there is a “definite and firm conviction” that a mistake was made. This makes it harder to reverse lower court decisions unless there is overwhelming evidence.
  • Extrinsic Evidence: When a contract is considered ambiguous, courts may use evidence and materials outside the document itself to interpret its meaning. In this case, previous judicial opinions and scientific literature were used to further understand what constitutes a valid diagnosis of Death with CTE.

Conclusion

In summary, the Third Circuit’s decision to affirm the District Court’s ruling represents a clarifying moment in the context of NFL concussion litigation. The judgment highlights a pivotal legal principle: a diagnosis of Death with CTE – as required by the NFL Concussion Settlement Agreement – unequivocally requires a post-mortem brain tissue examination by a board-certified neuropathologist. Relying on both contract interpretation and solid scientific principles endorsed in previous precedents, the Court concluded that claims which fail to meet this standard do not warrant compensation.

This decision not only reinforces the importance of adhering to the strict diagnostic procedures agreed upon in the settlement but also serves as an instructive example of how judicial messages and scientific standards intersect in legal disputes. As future cases emerge, this judgment is poised to influence litigation involving technical or scientific evidentiary standards, ensuring that contractual promises tied to specialized criteria are executed rigorously and with due deference to expert opinions.

Case Details

Year: 2025
Court: United States Court of Appeals, Third Circuit

Judge(s)

FREEMAN, CIRCUIT JUDGE

Attorney(S)

David J. Campbell [ARGUED] Thompson & Horton Counsel for Appellants Lynn B. Bayard Bruce A. Birenboim Brad S. Karp Kannon K. Shanmugam [ARGUED] Paul, Weiss, Rifkind, Wharton & Garrison LLP Counsel for Appellees

Comments